Correlation Between Lyra Therapeutics and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Nuvation Bio, you can compare the effects of market volatilities on Lyra Therapeutics and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Nuvation Bio.
Diversification Opportunities for Lyra Therapeutics and Nuvation Bio
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lyra and Nuvation is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Nuvation Bio go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Nuvation Bio
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Nuvation Bio. In addition to that, Lyra Therapeutics is 2.03 times more volatile than Nuvation Bio. It trades about -0.1 of its total potential returns per unit of risk. Nuvation Bio is currently generating about 0.24 per unit of volatility. If you would invest 235.00 in Nuvation Bio on August 28, 2024 and sell it today you would earn a total of 54.00 from holding Nuvation Bio or generate 22.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Lyra Therapeutics vs. Nuvation Bio
Performance |
| Timeline |
| Lyra Therapeutics |
| Nuvation Bio |
Lyra Therapeutics and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Nuvation Bio
The main advantage of trading using opposite Lyra Therapeutics and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Nuvation Bio vs. Eliem Therapeutics | Nuvation Bio vs. HCW Biologics | Nuvation Bio vs. Scpharmaceuticals | Nuvation Bio vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |